Physician profile
Cinyu Chi
NPI 1205521044
$3,633.17
in general payments reported to CMS, 2019-2025
7 companies · $3,365 in 2025
The $3,365 reported for 2025 was more than what 94% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $268 · 2025: $3,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,027 · Travel and Lodging: $1,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,026.83 |
| Travel and Lodging | $1,606.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,643.08 | 2025 | Inspire |
| Stryker Corporation | $275.67 | 2024-2025 | Core, Na, Patient-Fitted Tmj Reconstructive Prosthesis System |
| Polynovo North America LLC | $256.02 | 2025 | Novosorb Btm |
| Aerin Medical INC. | $166.74 | 2025 | |
| Acera Surgical, INC. | $149.46 | 2025 | Restrata Wound Matrix |
| Karl Storz Endoscopy-America | $112.08 | 2024-2025 | Solo+ Ttd Handpiece |
| Cochlear Americas | $30.12 | 2024 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cinyu Chi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.